Fang-Hong Chen

Fang-Hong Chen

Auto-generated profile, based on publicly available information

Fang-Hong Chen

Department of Urology, Medical College of Wisconsin, Milwaukee, WI, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2005 in BMC Urology
Verified
Journal Article
Open access
PDF file
FCFanghong Chen
Fanghong Chen
GZGuangjian Zhang
Guangjian Zhang
YIYoshiki Iwamoto
Yoshiki Iwamoto
WSWilliam A See
William A See
Background: Current models of the mechanism by which intravesical BCG induces an anti-tumor effect in urothelial carcinoma propose a secondary cellular immune response as principally responsible. Our group has demonstrated that BCG mediated cross-linking of α5"Equation missing"<!-- image only, no MathML or LaTex -->1 integrin receptors present on the tumor surface elicits a complex biologic response involving AP1 and NF-κB signaling as well as the transactivation of immediate early genes. This study evaluated the direct biologic effect of cross-linking α5β1 integrin on cell cycle progression and apoptosis in two human urothelial carcinoma cell lines. Methods: Two independent assays (MTT and Colony forming ability) were employed to measure the effect of α5β1 cross-linking (antibody mediated or BCG) on cellular proliferation. Flow cytometry was employed to measure effect of BCG and α5β1 antibody mediated cross-linking on cell cycle progression. Apoptosis was measured using assays for both DNA laddering and Caspase 3 activation. Results: Results demonstrate that integrin cross-linking by BCG, or antibody mediated crosslinking of α5β1 resulted in a decrease in proliferating cell number. BCG treatment or α5β1 cross-linking increased the percentage of cells in G0/G1, in both 253J and T24 cell lines. Peptide mediated blockade of integrin binding site using RGDS reversed the effect BCG on both proliferation and cell cycle arrest. Apoptosis in response to BCG was not identified by either DNA laddering or Caspase 3 activation. Conclusion: These findings show that BCG exerts a direct cytostatic effect on human urothelial carcinoma cell lines. Cell cycle arrest at the G1/S interface is a mechanism by which BCG inhibits cellular proliferation. This effect is duplicated by antibody mediated cross-linking of α5β1 and likely occurs as a consequence of crosslink-initiated signal transduction to cell cycle regulatory genes.

1 August 2002
Verified
Journal Article
Closed access
FCFang-Hong Chen
Fang-Hong Chen
SCScott A Crist
Scott A Crist
GZGuang-Jian Zhang
Guang-Jian Zhang
YIYoshiki Iwamoto
Yoshiki Iwamoto
WSWilliam A See
William A See